Glycemic Control and Clinical Outcomes in U.S. Patients With COVID-19: Data From the National COVID Cohort Collaborative (N3C) Database.
Rachel WongMargaret HallRohith VaddavalliAdit AnandNeha AroraCarolyn T BramanteVictor GarciaSteven JohnsonMary SaltzJena S TronieriYun Jae YooJohn B BuseJoel SaltzJoshua D MillerRichard Moffittnull nullPublished in: Diabetes care (2022)
In a large, multicenter cohort of patients in the U.S. with T2D and COVID-19 infection, risk of hospitalization increased with incrementally higher HbA1c levels. Risk of death and invasive ventilation also increased but plateaued at different levels of glycemic control.
Keyphrases
- glycemic control
- type diabetes
- blood glucose
- weight loss
- end stage renal disease
- insulin resistance
- coronavirus disease
- quality improvement
- newly diagnosed
- sars cov
- chronic kidney disease
- emergency department
- prognostic factors
- clinical trial
- electronic health record
- intensive care unit
- patient reported outcomes
- mechanical ventilation
- cross sectional
- machine learning
- patient reported
- deep learning
- respiratory failure